These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Strategies to overcome myelotoxic therapy for the treatment of Burkitt's and AIDS-related non-Hodgkin's lymphoma. Rochford R; Feuer G; Orem J; Banura C; Katongole-Mbidde E; Mwanda WO; Moormann A; Harrington WJ; Remick SC East Afr Med J; 2005 Sep; 82(9 Suppl):S155-60. PubMed ID: 16619692 [TBL] [Abstract][Full Text] [Related]
4. A study of the association of Epstein-Barr virus with Burkitt's lymphoma occurring in a Chinese population. Chan JK; Tsang WY; Ng CS; Wong CS; Lo ES Histopathology; 1995 Mar; 26(3):239-45. PubMed ID: 7797201 [TBL] [Abstract][Full Text] [Related]
5. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt: epidemiologic correlations. Anwar N; Kingma DW; Bloch AR; Mourad M; Raffeld M; Franklin J; Magrath I; el Bolkainy N; Jaffe ES Cancer; 1995 Oct; 76(7):1245-52. PubMed ID: 8630905 [TBL] [Abstract][Full Text] [Related]
6. Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. Rowe M; Kelly GL; Bell AI; Rickinson AB Semin Cancer Biol; 2009 Dec; 19(6):377-88. PubMed ID: 19619657 [TBL] [Abstract][Full Text] [Related]
7. Is endemic Burkitt's lymphoma an alliance between three infections and a tumour promoter? van den Bosch CA Lancet Oncol; 2004 Dec; 5(12):738-46. PubMed ID: 15581545 [TBL] [Abstract][Full Text] [Related]
8. Burkitt's lymphoma: the initial defining characteristics. Mwanda OW East Afr Med J; 2004 Aug; (8 Suppl):S63-7. PubMed ID: 15622604 [TBL] [Abstract][Full Text] [Related]
9. Clinical and demographic characteristics of Epstein-Barr virus-associated childhood Burkitt's lymphoma in Southeastern Brazil: epidemiological insights from an intermediate risk region. Hassan R; Klumb CE; Felisbino FE; Guiretti DM; White LR; Stefanoff CG; Barros MH; Seuánez HN; Zalcberg IR Haematologica; 2008 May; 93(5):780-3. PubMed ID: 18367488 [TBL] [Abstract][Full Text] [Related]
10. Burkitt's lymphoma and emerging therapeutic strategies for EBV and AIDS-associated lymphoproliferative diseases in East Africa. Mwanda WO; Whalen C; Remick SC East Afr Med J; 2005 Sep; 82(9 Suppl):S133-4. PubMed ID: 16619688 [No Abstract] [Full Text] [Related]
11. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines. Perez-Chacon G; de Los Rios C; Zapata JM Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456 [TBL] [Abstract][Full Text] [Related]
12. Analysis of African Burkitt's and high-grade B cell non-Burkitt's lymphoma for Epstein-Barr virus genomes using in situ hybridization. Prevot S; Hamilton-Dutoit S; Audouin J; Walter P; Pallesen G; Diebold J Br J Haematol; 1992 Jan; 80(1):27-32. PubMed ID: 1311194 [TBL] [Abstract][Full Text] [Related]
19. Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma. Toomey NL; Deyev VV; Wood C; Boise LH; Scott D; Liu LH; Cabral L; Podack ER; Barber GN; Harrington WJ Oncogene; 2001 Oct; 20(48):7029-40. PubMed ID: 11704827 [TBL] [Abstract][Full Text] [Related]
20. The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas. Cader FZ; Kearns P; Young L; Murray P; Vockerodt M Cancer Treat Rev; 2010 Jun; 36(4):348-53. PubMed ID: 20193983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]